We strive to be the leading provider of biopreservation tools for cells, tissues, and organs; to facilitate basic and applied research and commercialization of new therapies by maintaining the health and function of biologic source material and finished products during manufacturing, distribution, and clinical administration. More about BioLife →
Shop our line of cGMP BioPreservation products
Or contact us to talk to one of our biopreservation experts.
Kolon Life Science Launches Os...1 0 1
Kolon Life Science Launches Osteoarthritis Drug Invossa in Korea A huge congratulations to…...Read More
BioLife Solutions Announces Third Quarter 2017...
on November 9, 2017 at 9:05 pm
Revenue Increased 39% Over Prior Year […]
BioLife Solutions to Report Third Quarter 2017...
on November 2, 2017 at 10:30 am
BioLife Solutions and SAVSU Providing Enhanced...
on October 31, 2017 at 10:30 am
CryoStor® Cell Freeze Media and evo® Smart Shipper Embedded in Trials Using Treg Cells for Diabetes, Lupus, Pemphigus, and Organ Transplantation […]
BioLife Solutions Receives $1.9 Million from...
on October 30, 2017 at 10:30 am
BioLife Solutions Customer Kite Pharma Receives...
on October 19, 2017 at 10:30 am
Each Yescarta Dose is Frozen in Proprietary CryoStor® Freeze Media to Maintain CAR T-Cell Viability and Enable Worldwide Distribution […]